There is limited data on the expression of target genes of the miR-200 family in colorectal adenoma and, to the best of our knowledge, only CDKN1B and SOX2 have so far been investigated, excluding studies on dysplastic lesions in inflammatory bowel diseases. Here, CDKN1B is linked to inflammatory bowel disease.